XML 49 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2024 and 2023 are as follows:
  

Three and
nine months
ended
September 30,
2024

(Shares)

   Three and
nine months
ended
September 30, 
2023
(Shares)
 
Convertible debt   38,680,397    13,046,469 
Stock options   1,513,335    1,543,893 
Warrants to purchase shares of Common Stock   21,721,759    9,135,137 
    61,915,491    23,725,499